Srinivas Akkaraju, 10% Owner at Neurogene Inc. (NGNE), bought 95,540 shares at $27.50 ($2.5M) on 2024-11-26, disclosed to the SEC on 2024-11-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.91 | 20,748 | $517K | 21.0% |
| 2 | $24.91 | 20,748 | $517K | 21.0% |
| 3 | $26.01 | 10,803 | $281K | 11.4% |
| 4 | $26.01 | 10,803 | $281K | 11.4% |
| 5 | $26.73 | 15,219 | $407K | 16.5% |
| 6 | $26.73 | 15,219 |
| $407K |
| 16.5% |
| 7 | $27.50 | 2,000 | $55K | 2.2% |
| Total | $25.79 avg | 95,540 | $2.5M | 100% |
| Filing → |
| KLRS | BUY | 2026-05-22 | $1.2M | — | Filing → |
| ALMS | BUY | 2026-01-13 | $10.0M | — | Filing → |
| SRRK | BUY | 2025-12-16 | $1.9M | — | Filing → |